Literature DB >> 8675626

Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

V Atger1, M de la Llera Moya, M Bamberger, O Francone, P Cosgrove, A Tall, A Walsh, N Moatti, G Rothblat.   

Abstract

The ability of whole serum to promote cell cholesterol efflux and the relationships between apoprotein and lipoprotein components of human serum efflux have been investigated previously (de la Llera Moya, M., V. Atger, J.L. Paul, N. Fournier, N. Moatti, P. Giral, K.E. Friday, and G.H. Rothblat. 1994. Arterioscler. Thromb. 14:1056-1065). We have now used this experimental system to study the selective effects of two human lipoprotein-related proteins, apoprotein AI (apo AI) and cholesteryl ester transfer protein (CETP) on cell cholesterol efflux, when these proteins are expressed in transgenic mice. The percent efflux values for cholesterol released in 4 h from Fu5AH donor cells to 5% sera from the different groups of mice were in the order: background = human apo AI transgenic (HuAITg) > human CETP transgenic (HuCETPTg) > human apo AI and CETP transgenic (HuAICETPTg) >> apo AI knockout mice. In each group of mice a strong, positive correlation (r2 ranging from 0.64 to 0.76) was found between efflux and HDL cholesterol concentrations. The slopes of these regression lines differed between groups of mice, indicating that the cholesterol acceptor efficiencies of the sera differed among groups. These differences in relative efficiencies can explain why cholesterol efflux was not proportional to the different HDL levels in the various groups of mice. We can conclude that: (a) HDL particles from HuAITg mice are less efficient as cholesterol acceptors than HDL from the background mice; (b) despite a lower average efflux due to lower HDL cholesterol concentrations, HDL particles are more efficient in the HuCETPTg mice than in the background mice; and (c) the coexpression of both human apo AI and CETP improves the efficiency of HDL particles in the HuAICETPTg mice when compared with the HuAITg mice. We also demonstrated that the esterification of the free cholesterol released from the cells by lecithin cholesterol acyltransferase in the serum was reduced in the HuAITg and AI knockout mice, whereas it was not different from background values in the two groups of mice expressing human CETP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8675626      PMCID: PMC185966          DOI: 10.1172/JCI118326

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Initial steps in reverse cholesterol transport: the role of short-lived cholesterol acceptors.

Authors:  O L Francone; C J Fielding
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

Review 3.  Lipoproteins of human peripheral lymph.

Authors:  D Reichl
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

Review 4.  Lipoproteins in interstitial fluid of dogs: implications for a role in reverse cholesterol transport.

Authors:  P S Roheim; L Dory; M Lefevre; C H Sloop
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

Review 5.  Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

Authors:  D Reichl; N E Miller
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

6.  Tissue-specific posttranslational modification of rat apoE. Synthesis of sialated apoE forms by neonatal rat aortic smooth muscle cells.

Authors:  M M Hussain; N L Bucher; B Faris; C Franzblau; V I Zannis
Journal:  J Lipid Res       Date:  1988-07       Impact factor: 5.922

7.  Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice.

Authors:  L B Agellon; A Walsh; T Hayek; P Moulin; X C Jiang; S A Shelanski; J L Breslow; A R Tall
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

8.  Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells.

Authors:  A Steinmetz; R Barbaras; N Ghalim; V Clavey; J C Fruchart; G Ailhaud
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

9.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

Authors:  E M Rubin; B Y Ishida; S M Clift; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

10.  Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol.

Authors:  O L Francone; A Gurakar; C Fielding
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

View more
  11 in total

1.  Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.

Authors:  O Stein; Y Dabach; G Hollander; M Ben-Naim; G Halperin; J L Breslow; Y Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.

Authors:  V M Atger; M de la Llera Moya; G W Stoudt; W V Rodrigueza; M C Phillips; G H Rothblat
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.

Authors:  P Holvoet; S Danloy; E Deridder; M Lox; H Bernar; A Dhoest; D Collen
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

Review 5.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

Review 6.  CETP and exchangeable apoproteins: common features in lipid binding activity.

Authors:  V M Bolaños-García; M Soriano-García; J Mas-Oliva
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

7.  Human cholesteryl ester transport protein transgene promotes macrophage reverse cholesterol transport in C57BL/6 mice and phospholipid transfer protein gene knockout mice.

Authors:  Na Liu; Yanhong Si; Ying Zhang; Shoudong Guo; Shucun Qin
Journal:  J Physiol Biochem       Date:  2021-08-17       Impact factor: 4.158

Review 8.  Endothelial lipase: its role in cardiovascular disease.

Authors:  Marie-Eve Paradis; Benoit Lamarche
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

9.  Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.

Authors:  Baohai Shao; Chongren Tang; Abhishek Sinha; Philip S Mayer; George D Davenport; Nathan Brot; Michael N Oda; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Circ Res       Date:  2014-03-19       Impact factor: 17.367

10.  Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.

Authors:  Sarah R Breevoort; Jerry Angdisen; Ira G Schulman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.